ID GLCE_HUMAN Reviewed; 617 AA. AC O94923; Q6GUQ2; DT 15-NOV-2002, integrated into UniProtKB/Swiss-Prot. DT 16-JUN-2009, sequence version 3. DT 27-MAR-2024, entry version 174. DE RecName: Full=D-glucuronyl C5-epimerase; DE EC=5.1.3.17 {ECO:0000269|PubMed:20118238, ECO:0000269|PubMed:22528493, ECO:0000269|PubMed:30872481}; DE AltName: Full=Heparan sulfate C5-epimerase; DE Short=Hsepi; DE AltName: Full=Heparin/heparan sulfate:glucuronic acid C5-epimerase; DE AltName: Full=Heparosan-N-sulfate-glucuronate 5-epimerase; GN Name=GLCE; Synonyms=KIAA0836 {ECO:0000312|EMBL:BAA74859.1}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606 {ECO:0000312|EMBL:BAA74859.1}; RN [1] {ECO:0000312|EMBL:AAT48654.1} RP NUCLEOTIDE SEQUENCE [MRNA]. RA Ghiselli G.; RT "Homo sapiens D-glucuronyl C5-epimerase (GLCE)."; RL Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16572171; DOI=10.1038/nature04601; RA Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K., RA Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K., RA FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N., RA Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S., RA Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K., RA DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J., RA Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E., RA Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B., RA Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R., RA O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B., RA Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S., RA Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.; RT "Analysis of the DNA sequence and duplication history of human chromosome RT 15."; RL Nature 440:671-675(2006). RN [3] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-617, AND VARIANT ILE-597. RC TISSUE=Brain; RX PubMed=10048485; DOI=10.1093/dnares/5.6.355; RA Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N., RA Tanaka A., Kotani H., Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XII. The RT complete sequences of 100 new cDNA clones from brain which code for large RT proteins in vitro."; RL DNA Res. 5:355-364(1998). RN [4] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-225. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). RN [5] RP CATALYTIC ACTIVITY, FUNCTION, AND MUTAGENESIS OF TYR-146; TYR-162; TYR-168; RP TYR-210 AND TYR-222. RX PubMed=20118238; DOI=10.1074/jbc.m109.081059; RA Li K., Bethea H.N., Liu J.; RT "Using engineered 2-O-sulfotransferase to determine the activity of heparan RT sulfate C5-epimerase and its mutants."; RL J. Biol. Chem. 285:11106-11113(2010). RN [6] RP FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY. RX PubMed=22528493; DOI=10.1074/jbc.m112.359885; RA Sheng J., Xu Y., Dulaney S.B., Huang X., Liu J.; RT "Uncovering a biphasic catalytic mode of C5-epimerase in heparan sulfate RT biosynthesis."; RL J. Biol. Chem. 287:20996-21002(2012). RN [7] {ECO:0007744|PDB:6HZZ, ECO:0007744|PDB:6I01, ECO:0007744|PDB:6I02} RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 98-617 OF WILD-TYPE AND MUTANT RP PHE-578 IN COMPLEXES WITH CALCIUM AND SUBSTRATE ANALOGS, FUNCTION, RP CATALYTIC ACTIVITY, SUBUNIT, PATHWAY, GLYCOSYLATION AT ASN-225; ASN-303 AND RP ASN-393, AND MUTAGENESIS OF GLU-499; TYR-500 AND TYR-578. RX PubMed=30872481; DOI=10.1073/pnas.1818333116; RA Debarnot C., Monneau Y.R., Roig-Zamboni V., Delauzun V., Le Narvor C., RA Richard E., Henault J., Goulet A., Fadel F., Vives R.R., Priem B., RA Bonnaffe D., Lortat-Jacob H., Bourne Y.; RT "Substrate binding mode and catalytic mechanism of human heparan sulfate d- RT glucuronyl C5 epimerase."; RL Proc. Natl. Acad. Sci. U.S.A. 116:6760-6765(2019). CC -!- FUNCTION: Converts D-glucuronic acid residues adjacent to N-sulfate CC sugar residues to L-iduronic acid residues, both in maturing heparan CC sulfate (HS) and heparin chains. This is important for further CC modifications that determine the specificity of interactions between CC these glycosaminoglycans and proteins. {ECO:0000269|PubMed:20118238, CC ECO:0000269|PubMed:22528493, ECO:0000269|PubMed:30872481}. CC -!- CATALYTIC ACTIVITY: CC Reaction=[heparosan-N-sulfate](n) = [heparan-N-sulfate](n); CC Xref=Rhea:RHEA:20197, Rhea:RHEA-COMP:9556, Rhea:RHEA-COMP:9557, CC ChEBI:CHEBI:58041, ChEBI:CHEBI:58287; EC=5.1.3.17; CC Evidence={ECO:0000269|PubMed:20118238, ECO:0000269|PubMed:22528493, CC ECO:0000269|PubMed:30872481}; CC -!- PATHWAY: Glycan metabolism; heparan sulfate biosynthesis. CC {ECO:0000305|PubMed:22528493, ECO:0000305|PubMed:30872481}. CC -!- PATHWAY: Glycan metabolism; heparin biosynthesis. {ECO:0000305}. CC -!- SUBUNIT: Homodimer (PubMed:30872481). Interacts with HS2ST1. CC {ECO:0000250|UniProtKB:Q9EPS3, ECO:0000269|PubMed:30872481}. CC -!- SUBCELLULAR LOCATION: Golgi apparatus membrane CC {ECO:0000250|UniProtKB:Q9EPS3}; Single-pass type II membrane protein CC {ECO:0000250|UniProtKB:Q9EPS3}. CC -!- SIMILARITY: Belongs to the D-glucuronyl C5-epimerase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY635582; AAT48654.1; -; mRNA. DR EMBL; AC026992; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AB020643; BAA74859.1; -; mRNA. DR CCDS; CCDS32277.1; -. DR RefSeq; NP_001311022.1; NM_001324093.1. DR RefSeq; NP_001311023.1; NM_001324094.1. DR RefSeq; NP_056369.1; NM_015554.2. DR RefSeq; XP_005254355.1; XM_005254298.3. DR PDB; 6HZZ; X-ray; 2.52 A; A/B=98-617. DR PDB; 6I01; X-ray; 2.10 A; A/B=98-617. DR PDB; 6I02; X-ray; 2.45 A; A/B=98-617. DR PDBsum; 6HZZ; -. DR PDBsum; 6I01; -. DR PDBsum; 6I02; -. DR AlphaFoldDB; O94923; -. DR SMR; O94923; -. DR BioGRID; 117501; 52. DR IntAct; O94923; 20. DR MINT; O94923; -. DR STRING; 9606.ENSP00000261858; -. DR GlyCosmos; O94923; 4 sites, 1 glycan. DR GlyGen; O94923; 6 sites, 2 O-linked glycans (3 sites). DR iPTMnet; O94923; -. DR PhosphoSitePlus; O94923; -. DR SwissPalm; O94923; -. DR BioMuta; GLCE; -. DR EPD; O94923; -. DR jPOST; O94923; -. DR MassIVE; O94923; -. DR MaxQB; O94923; -. DR PaxDb; 9606-ENSP00000261858; -. DR PeptideAtlas; O94923; -. DR ProteomicsDB; 50559; -. DR Pumba; O94923; -. DR Antibodypedia; 26368; 80 antibodies from 13 providers. DR DNASU; 26035; -. DR Ensembl; ENST00000261858.7; ENSP00000261858.2; ENSG00000138604.10. DR GeneID; 26035; -. DR KEGG; hsa:26035; -. DR MANE-Select; ENST00000261858.7; ENSP00000261858.2; NM_015554.3; NP_056369.1. DR UCSC; uc002ary.2; human. DR AGR; HGNC:17855; -. DR CTD; 26035; -. DR DisGeNET; 26035; -. DR GeneCards; GLCE; -. DR HGNC; HGNC:17855; GLCE. DR HPA; ENSG00000138604; Tissue enhanced (brain). DR MIM; 612134; gene. DR neXtProt; NX_O94923; -. DR OpenTargets; ENSG00000138604; -. DR PharmGKB; PA145148750; -. DR VEuPathDB; HostDB:ENSG00000138604; -. DR eggNOG; KOG3760; Eukaryota. DR GeneTree; ENSGT00390000006043; -. DR InParanoid; O94923; -. DR OMA; RGVFMYF; -. DR OrthoDB; 5392022at2759; -. DR PhylomeDB; O94923; -. DR TreeFam; TF105869; -. DR BRENDA; 5.1.3.17; 2681. DR PathwayCommons; O94923; -. DR Reactome; R-HSA-2022928; HS-GAG biosynthesis. DR SignaLink; O94923; -. DR UniPathway; UPA00756; -. DR UniPathway; UPA00862; -. DR BioGRID-ORCS; 26035; 16 hits in 1123 CRISPR screens. DR ChiTaRS; GLCE; human. DR GeneWiki; GLCE; -. DR GenomeRNAi; 26035; -. DR Pharos; O94923; Tbio. DR PRO; PR:O94923; -. DR Proteomes; UP000005640; Chromosome 15. DR RNAct; O94923; Protein. DR Bgee; ENSG00000138604; Expressed in cerebellar hemisphere and 166 other cell types or tissues. DR ExpressionAtlas; O94923; baseline and differential. DR GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB. DR GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB. DR GO; GO:0047464; F:heparosan-N-sulfate-glucuronate 5-epimerase activity; IDA:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB. DR GO; GO:0016857; F:racemase and epimerase activity, acting on carbohydrates and derivatives; ISS:UniProtKB. DR GO; GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IDA:UniProtKB. DR GO; GO:0030210; P:heparin biosynthetic process; ISS:UniProtKB. DR GO; GO:0031345; P:negative regulation of cell projection organization; IEA:Ensembl. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl. DR GO; GO:0060391; P:positive regulation of SMAD protein signal transduction; IEA:Ensembl. DR InterPro; IPR010598; C5-epim_C. DR InterPro; IPR039721; C5-epimerase. DR PANTHER; PTHR13174; D-GLUCURONYL C5-EPIMERASE; 1. DR PANTHER; PTHR13174:SF3; D-GLUCURONYL C5-EPIMERASE; 1. DR Pfam; PF06662; C5-epim_C; 1. DR Pfam; PF21174; Glce_b_sandwich; 1. DR Genevisible; O94923; HS. PE 1: Evidence at protein level; KW 3D-structure; Calcium; Glycoprotein; Golgi apparatus; Isomerase; Membrane; KW Metal-binding; Reference proteome; Signal-anchor; Transmembrane; KW Transmembrane helix. FT CHAIN 1..617 FT /note="D-glucuronyl C5-epimerase" FT /id="PRO_0000192645" FT TOPO_DOM 1..11 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 12..28 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 29..617 FT /note="Lumenal" FT /evidence="ECO:0000255" FT BINDING 180 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 185..187 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 202 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 210 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 213 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I02" FT BINDING 216 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 238 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6HZZ, ECO:0007744|PDB:6I01, FT ECO:0007744|PDB:6I02" FT BINDING 240 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6HZZ, ECO:0007744|PDB:6I01, FT ECO:0007744|PDB:6I02" FT BINDING 268 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6HZZ, ECO:0007744|PDB:6I01, FT ECO:0007744|PDB:6I02" FT BINDING 269 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6HZZ, ECO:0007744|PDB:6I01, FT ECO:0007744|PDB:6I02" FT BINDING 392 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6HZZ, ECO:0007744|PDB:6I01, FT ECO:0007744|PDB:6I02" FT BINDING 429..432 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:F1QR43" FT BINDING 499..500 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 510 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 514 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 560 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 563 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT BINDING 572..581 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6I01" FT SITE 180 FT /note="Critical for catalysis" FT /evidence="ECO:0000250|UniProtKB:F1QR43" FT SITE 187 FT /note="Critical for catalysis" FT /evidence="ECO:0000250|UniProtKB:F1QR43" FT SITE 560 FT /note="Critical for catalysis" FT /evidence="ECO:0000250|UniProtKB:F1QR43" FT SITE 578 FT /note="Critical for catalysis" FT /evidence="ECO:0000269|PubMed:30872481" FT CARBOHYD 225 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218, FT ECO:0000269|PubMed:30872481, ECO:0007744|PDB:6HZZ, FT ECO:0007744|PDB:6I01, ECO:0007744|PDB:6I02" FT CARBOHYD 303 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6HZZ, ECO:0007744|PDB:6I01, FT ECO:0007744|PDB:6I02" FT CARBOHYD 393 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:30872481, FT ECO:0007744|PDB:6HZZ, ECO:0007744|PDB:6I01, FT ECO:0007744|PDB:6I02" FT VARIANT 65 FT /note="M -> V (in dbSNP:rs12440300)" FT /id="VAR_055837" FT VARIANT 597 FT /note="V -> I (in dbSNP:rs3865014)" FT /evidence="ECO:0000269|PubMed:10048485" FT /id="VAR_057958" FT MUTAGEN 146 FT /note="Y->A: Reduces enzyme activity by about 60%." FT /evidence="ECO:0000269|PubMed:20118238" FT MUTAGEN 162 FT /note="Y->A: Reduces enzyme activity by about 75%." FT /evidence="ECO:0000269|PubMed:20118238" FT MUTAGEN 168 FT /note="Y->A: Almost abolishes enzyme activity." FT /evidence="ECO:0000269|PubMed:20118238" FT MUTAGEN 210 FT /note="Y->A: Reduces enzyme activity by about 30%." FT /evidence="ECO:0000269|PubMed:20118238" FT MUTAGEN 222 FT /note="Y->A: Almost abolishes enzyme activity." FT /evidence="ECO:0000269|PubMed:20118238" FT MUTAGEN 499 FT /note="E->Q: Loss of enzyme activity." FT /evidence="ECO:0000269|PubMed:30872481" FT MUTAGEN 500 FT /note="Y->F: Mildly decreased enzyme activity." FT /evidence="ECO:0000269|PubMed:30872481" FT MUTAGEN 578 FT /note="Y->F: Loss of enzyme activity." FT /evidence="ECO:0000269|PubMed:30872481" FT STRAND 105..111 FT /evidence="ECO:0007829|PDB:6I01" FT TURN 112..114 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 115..122 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 125..129 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 130..137 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 140..146 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 149..156 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 177..179 FT /evidence="ECO:0007829|PDB:6I01" FT TURN 182..184 FT /evidence="ECO:0007829|PDB:6I02" FT STRAND 188..191 FT /evidence="ECO:0007829|PDB:6I01" FT TURN 193..195 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 197..200 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 202..204 FT /evidence="ECO:0007829|PDB:6HZZ" FT HELIX 211..227 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 233..237 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 239..241 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 244..246 FT /evidence="ECO:0007829|PDB:6I02" FT STRAND 257..263 FT /evidence="ECO:0007829|PDB:6I01" FT TURN 264..267 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 268..275 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 282..290 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 293..314 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 318..326 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 330..333 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 336..340 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 348..353 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 354..362 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 366..369 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 377..398 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 401..415 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 439..441 FT /evidence="ECO:0007829|PDB:6HZZ" FT HELIX 444..461 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 464..472 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 473..478 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 481..483 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 487..490 FT /evidence="ECO:0007829|PDB:6I01" FT TURN 491..493 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 494..497 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 509..530 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 532..548 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 549..552 FT /evidence="ECO:0007829|PDB:6I01" FT STRAND 555..560 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 563..567 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 576..589 FT /evidence="ECO:0007829|PDB:6I01" FT TURN 590..592 FT /evidence="ECO:0007829|PDB:6I01" FT HELIX 596..608 FT /evidence="ECO:0007829|PDB:6I01" FT TURN 609..611 FT /evidence="ECO:0007829|PDB:6I01" SQ SEQUENCE 617 AA; 70101 MW; 2F909A15FEA6DA05 CRC64; MRCLAARVNY KTLIIICALF TLVTVLLWNK CSSDKAIQFP RRSSSGFRVD GFEKRAAASE SNNYMNHVAK QQSEEAFPQE QQKAPPVVGG FNSNVGSKVL GLKYEEIDCL INDEHTIKGR REGNEVFLPF TWVEKYFDVY GKVVQYDGYD RFEFSHSYSK VYAQRAPYHP DGVFMSFEGY NVEVRDRVKC ISGVEGVPLS TQWGPQGYFY PIQIAQYGLS HYSKNLTEKP PHIEVYETAE DRDKNKPNDW TVPKGCFMAN VADKSRFTNV KQFIAPETSE GVSLQLGNTK DFIISFDLKF LTNGSVSVVL ETTEKNQLFT IHYVSNAQLI AFKERDIYYG IGPRTSWSTV TRDLVTDLRK GVGLSNTKAV KPTKIMPKKV VRLIAKGKGF LDNITISTTA HMAAFFAASD WLVRNQDEKG GWPIMVTRKL GEGFKSLEPG WYSAMAQGQA ISTLVRAYLL TKDHIFLNSA LRATAPYKFL SEQHGVKAVF MNKHDWYEEY PTTPSSFVLN GFMYSLIGLY DLKETAGEKL GKEARSLYER GMESLKAMLP LYDTGSGTIY DLRHFMLGIA PNLARWDYHT THINQLQLLS TIDESPVFKE FVKRWKSYLK GSRAKHN //